FDA approves nasal spray for treatment-resistant depression
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
HealthDay on MSN11h
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...
Hosted on MSN5h
Can Taking Antidepressants Cause Weight Loss?
If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...
World Finance7h
Pandemics and economics: The price of being unprepared
The Covid-19 outbreak in 2020 was on a scale not seen since the Spanish flu pandemic in 1918 and laid bare our lack of ...
TikTok is back—and it's harming kids 'at an industrial scale,' says psychologist
After briefly going dark in the U.S., TikTok is back online following an executive order. That's not good for young users, ...
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer and dementia, a sweeping ...